Boehringer, Teva Sued Over $120M Pay-For-Delay Deal
Drug distributor American Sales Co. on Thursday hit Boehringer Ingelheim Pharmaceuticals Inc. and Teva Pharmaceuticals USA Inc. with a proposed class action over an alleged $120 million pay-for-delay deal, the latest...To view the full article, register now.
Already a subscriber? Click here to view full article